| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
39,144,883 | 37,177,945 | 35,071,161 | 31,807,491 | 30,757,777 |
| Cost of Revenue
|
-30,960,754 | -29,410,067 | -28,257,835 | -26,139,696 | -25,517,225 |
|
Gross Profit
|
8,184,129 | 7,767,878 | 6,813,326 | 5,667,795 | 5,240,552 |
| Selling, General and Administrative Expenses
|
-2,967,632 | -2,820,334 | -2,819,714 | -2,586,765 | -2,433,032 |
|
Research and Development Expenses
|
-612,890 | -629,267 | -670,781 | -613,594 | -573,913 |
|
Operating Income/Expenses
|
-3,580,522 | -3,449,601 | -3,490,495 | -3,200,359 | -3,006,945 |
|
Total Operating Profit/Loss
|
4,603,607 | 4,318,277 | 3,322,831 | 2,467,436 | 2,233,607 |
| Total Net Finance Income/Expense
|
12,353 | 21,308 | 29,623 | -9,455 | -13,986 |
| Net Investment Income
|
196,495 | 13,098 | 333,339 | 307,514 | 265,030 |
| Irregular Income/Expenses
|
-11,342 | -19,091 | 32,227 | -3,317 | 20,970 |
|
Other Income/Expense, Non-Operating
|
153,013 | -63,859 | 285,370 | 352,143 | 249,988 |
|
Non-Operating Income/Expenses, Total
|
350,519 | -48,544 | 680,559 | 646,885 | 522,002 |
|
Pretax Income
|
4,954,126 | 4,269,733 | 4,003,390 | 3,114,321 | 2,755,609 |
|
Provision for Income Tax
|
-1,024,431 | -892,106 | -859,652 | -654,659 | -633,460 |
|
Net Income from Continuing Operations
|
3,929,695 | 3,377,627 | 3,143,738 | 2,459,662 | 2,122,149 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
3,929,695 | 3,377,627 | 3,143,738 | 2,459,662 | 2,122,149 |
|
Non-Controlling/Minority Interests
|
-149,705 | -109,817 | -117,997 | -111,393 | -112,249 |
|
Net Income after Non-Controlling/Minority Interests
|
3,779,990 | 3,267,810 | 3,025,741 | 2,348,269 | 2,009,900 |
|
Net Income Available to Common Stockholders
|
3,779,990 | 3,267,810 | 3,025,741 | 2,348,269 | 2,009,900 |
|
Diluted Net Income Available to Common Stockholders
|
3,779,990 | 3,267,810 | 3,025,741 | 2,348,269 | 2,009,900 |
| Basic EPS
|
7.26 | 6.27 | 5.81 | 4.51 | 3.86 |
| Diluted EPS
|
7.25 | 6.26 | 5.80 | 4.50 | 3.84 |
|
Basic Weighted Average Shares Outstanding
|
520,768.13 | 521,181.82 | 520,781.58 | 520,680.49 | 520,699.48 |
|
Diluted Weighted Average Shares Outstanding
|
522,118.32 | 522,014.38 | 521,679.48 | 521,837.56 | 523,411.46 |
|
EBIT
|
4,941,773 | 4,248,425 | 3,973,767 | 3,123,776 | 2,769,595 |
|
EBITDA
|
5,765,341 | 5,065,434 | 4,768,868 | 3,881,598 | 3,501,352 |
|
Normalized EBITDA
|
5,773,974 | 5,199,768 | 4,692,074 | 3,753,400 | 3,500,482 |
|
Normalized Income
|
3,936,542.84 | 3,483,893.66 | 3,083,434.05 | 2,358,412.37 | 2,121,479 |
|
Total Unusual Items
|
8,633 | 134,334 | -76,794 | -128,198 | -870 |
|
Total Unusual Items Excluding Goodwill
|
8,633 | 134,334 | -76,794 | -128,198 | -870 |
12/31/2022 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade